New Delhi: US-based Bristol Myers Squibb (BMS) on Thursday filed a motion in the Supreme Court to prevent Ahmedabad-based Zydus Lifesciences from manufacturing and selling a biosimilar version of ...
New Delhi | Mumbai: The government is giving final touches to a revised set of regulations to set stringent quality standards for research and manufacture of biosimilar drugs, which ...
Biocon Biologics, the subsidiary of Biocon on Saturday has received the USFDA nod to launch the biosimilar version of Janssen's Stelara (Ustekinumab) used for the treatment of autoimmune disorders ...